Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 16, 2017
Clinical News

Kevetrin: Ph IIa started

BioCentury | Nov 2, 2016
Clinical News

Prurisol: Ph IIb started

BioCentury | Jun 27, 2016
Clinical News

Brilacidin: Phase II started

BioCentury | Mar 7, 2016
Clinical News

Prurisol abacavir acetate: Phase II ongoing

BioCentury | Aug 24, 2015
Clinical News

Thioureidobutyronitrile: Interim Phase I data

BioCentury | Aug 17, 2015
Clinical News

Abacavir acetate: Phase II started

BioCentury | Jun 15, 2015
Clinical News

Brilacidin-OM: Phase II started

Items per page:
1 - 10 of 54